These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 1420650

  • 1. Asterixis induced by carbamazepine therapy.
    Rittmannsberger H, Leblhuber F.
    Biol Psychiatry; 1992 Aug 15; 32(4):364-8. PubMed ID: 1420650
    [Abstract] [Full Text] [Related]

  • 2. Asterixis induced by psychotropic drug treatment.
    Rittmannsberger H.
    Clin Neuropharmacol; 1996 Aug 15; 19(4):349-55. PubMed ID: 8828998
    [Abstract] [Full Text] [Related]

  • 3. Asterixis as a side effect of carbamazepine therapy.
    Rittmannsberger H, Leblhuber F, Sommer R.
    Klin Wochenschr; 1991 Apr 04; 69(6):279-81. PubMed ID: 1674759
    [Abstract] [Full Text] [Related]

  • 4. Hyperammonemia in asterixis induced by carbamazepine: two case reports.
    Ambrosetto G, Riva R, Baruzzi A.
    Acta Neurol Scand; 1984 Mar 04; 69(3):186-9. PubMed ID: 6720252
    [Abstract] [Full Text] [Related]

  • 5. The treatment of affective disorder with carbamazepine: prophylactic synergism of lithium and carbamazepine combination.
    Kishimoto A.
    Prog Neuropsychopharmacol Biol Psychiatry; 1992 Jul 04; 16(4):483-93. PubMed ID: 1641493
    [Abstract] [Full Text] [Related]

  • 6. Comparison of the antimanic efficacy of carbamazepine and lithium carbonate by double-blind controlled study.
    Okuma T, Yamashita I, Takahashi R, Itoh H, Otsuki S, Watanabe S, Sarai K, Hazama H, Inanaga K.
    Pharmacopsychiatry; 1990 May 04; 23(3):143-50. PubMed ID: 1973844
    [Abstract] [Full Text] [Related]

  • 7. Lithium counteracts carbamazepine-induced leukopenia while increasing its therapeutic effect.
    Brewerton TD.
    Biol Psychiatry; 1986 Jun 04; 21(7):677-85. PubMed ID: 3708039
    [No Abstract] [Full Text] [Related]

  • 8. [Carbamazepine-fluvoxamine interaction. Consequences for the carbamazepine plasma level].
    Cottencin O, Regnaut N, Thévenon-Gignac C, Thomas P, Goudemand M, Debruille C, Robert H.
    Encephale; 1995 Jun 04; 21(2):141-5. PubMed ID: 7781585
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Doubleblind evaluation of the antimanic properties of carbamazepine as a comedication to haloperidol.
    Möller HJ, Kissling W, Riehl T, Bäuml J, Binz U, Wendt G.
    Prog Neuropsychopharmacol Biol Psychiatry; 1989 Jun 04; 13(1-2):127-36. PubMed ID: 2664882
    [Abstract] [Full Text] [Related]

  • 12. Extrapyramidal syndrome related to lithium-carbamazepine combination therapy at therapeutic serum levels.
    Palma JA, Fernandez-Torron R, Gallego Perez-Larraya J.
    Clin Neuropharmacol; 2010 Jun 04; 33(2):102-3. PubMed ID: 20375657
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The long-term management of bipolar disorders with lithium, carbamazepine, and antidepressants.
    Fawcett J, Kravitz HM.
    J Clin Psychiatry; 1985 Feb 04; 46(2):58-60. PubMed ID: 3968046
    [Abstract] [Full Text] [Related]

  • 15. Safety of carbamazepine extended-release capsules in bipolar disorder polypharmacy.
    Ginsberg LD.
    Ann Clin Psychiatry; 2006 Feb 04; 18 Suppl 1():19-22. PubMed ID: 16754408
    [Abstract] [Full Text] [Related]

  • 16. Lithium-carbamazepine neurotoxicity and risk factors.
    Shukla S, Godwin CD, Long LE, Miller MG.
    Am J Psychiatry; 1984 Dec 04; 141(12):1604-6. PubMed ID: 6439058
    [Abstract] [Full Text] [Related]

  • 17. Carbamazepine extended-release capsules use in bipolar disorder: efficacy and safety in adult patients.
    Ginsberg LD.
    Ann Clin Psychiatry; 2006 Dec 04; 18 Suppl 1():9-14. PubMed ID: 16754406
    [Abstract] [Full Text] [Related]

  • 18. [Drug-induced asterixis].
    Rittmannsberger H, Leblhuber F.
    Dtsch Med Wochenschr; 1994 Apr 22; 119(16):585-8. PubMed ID: 8162841
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Bipolar I and II disorder residual symptoms: oxcarbazepine and carbamazepine as add-on treatment to lithium in a double-blind, randomized trial.
    Juruena MF, Ottoni GL, Machado-Vieira R, Carneiro RM, Weingarthner N, Marquardt AR, Fleig SS, Broilo L, Busnello EA.
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Feb 01; 33(1):94-9. PubMed ID: 19007842
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.